MetVital, Inc.
🇺🇸United States
Trial of AEO in New Glioblastoma (GBM)
Phase 2
- Conditions
- Glioblastoma Multiforme
- Interventions
- Other: Standard of CareDrug: Anhydrous Enol-Oxaloacetate (AEO)
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- MetVital, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04450160
© Copyright 2025. All Rights Reserved by MedPath